(Q34430548)

English

Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

randomized controlled trial

1 reference

based on heuristic

inferred from title

chronic fatigue syndrome

1 reference

based on heuristic

inferred from title

author name string

Rowe KS

1

1 reference

Europe PubMed Central

2 August 2017

publication date

1 January 1997

1 reference

Europe PubMed Central

2 August 2017

Journal of Psychiatric Research

1 reference

Europe PubMed Central

2 August 2017

31

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

133-147

1 reference

Europe PubMed Central

2 August 2017

Immunologic abnormalities associated with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

The postviral fatigue syndrome--an analysis of the findings in 50 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Clinical uses of intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Differentiating depression in medically ill children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Chronic fatigue syndrome: a working case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

WHAT IS MYALGIC ENCEPHALOMYELITIS?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Immunological abnormalities in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

PATHOPHYSIOLOGY OF MYALGIC ENCEPHALITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Longitudinal study of outcome of chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900047-7

7 January 2021

Identifiers

10.1016/S0022-3956(96)00047-7

1 reference

Europe PubMed Central

2 August 2017

release_4nskum67uba4zb74i2d2xhbtdy

1 reference

https://api.fatcat.wiki/v0/release/4nskum67uba4zb74i2d2xhbtdy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34430548&oldid=1844822451"